Low Gradient Aortic Stenosis Won’t Improve with TAVR

Courtesy of Dr. Carlos Fava.

Low Gradient Aortic Stenosis Won’t Improve with TAVRIt is known that patients with low gradient aortic stenosis show poor evolution with medical treatment and, in addition, present high mortality rate with surgery. As regards TAVR, a far simpler procedure compared to surgery, there is contradicting evidence; while some studies claim it holds comparable risks, others have found benefits.

 

This study analyzed 8 studies including a total of 12,589 patients. Low gradient aortic stenosis was defined as aortic valve area (AVA) <1 cm2 with a mean gradient lower than 40 mmHg, except for Malkin, who defined it as AVA <1.

 

Primary end point was all cause mortality at 12 months, while the secondary was all cause mortality at 30 days.

 

All patients presented severe symptomatic aortic stenosis. 3,437 (27.3%) of them presented low gradient aortic stenosis.

 

Mean age was 81. Ejection fraction was lower in those presenting low gradient aortic stenosis (48% vs. 54%), higher presence of diabetes, coronary artery disease and EuroSCORE log.

 

Primary end point was higher in the low gradient AS group (OR; 1.48; 95% CI; 1.3-1.7; p<0.00001), as well as the secondary end point (OR, 1.35; 95% CI, 1.11-1.66; p=0.002). As regards age, ejection fraction, a history of heart disease and type of implanted valve, these factors did not impact mortality in the low gradient group.

 

Conclusion

In a population of patients undergoing TAVR, the presence of low gradient aortic stenosis seems to be associated to a dismal prognosis.

 

Comment

The presence of low flow and low gradient is a challenge in this disease, since it is associated with higher early mortality after surgery, and this analyzis shows the same.

We should learn to be wary not only of AS diagnosis (acknowledging symptoms, assessing ventricular function and ejection fraction), but also of systolic volume index, associated to early ventricular function deterioration.

 

Courtesy of Dr. Carlos Fava.

 

Original Title: Outcomes of Patients with Low-Pressure Aortic Gradient Undergoing Transcatheter Aortic Valve Implantation: a Meta-analysis.

Reference: Federico Carnotto, et al. Catheterization and Cardiovascular Intervention 2017;89:1100-1106.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...

HERA-TAVI: Intra-Annular vs Supra-Annular Valves in TAVI

 The HERA-TAVI study is an international multicenter registry that compared the clinical and hemodynamic outcomes of contemporary self-expanding transcatheter heart valves with intra-annular (IA)...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...